Literature DB >> 27567182

Memory γδ T Cells-Newly Appreciated Protagonists in Infection and Immunity.

Stephen J Lalor1, Rachel M McLoughlin2.   

Abstract

Despite the potential for diversity in their T cell receptor, γδ T cells are primarily considered to be innate immune cells. Recently, memory-like γδ T cell responses have been identified in murine models of infection and autoimmunity. Similar memory responses have also been described in human and non-human primate γδ T cells. It has thus become clear that subpopulations of γδ T cells can develop long-lasting memory akin to conventional αβ T cells, with protective and pathogenic consequences. Hence, a re-evaluation of their true capabilities and role in infection and immunity is required. This review discusses recent reports of memory-type responses attributed to γδ T cells and assesses this underappreciated facet of these enigmatic cells.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  autoimmunity; infection; memory; γδ T cells

Mesh:

Substances:

Year:  2016        PMID: 27567182     DOI: 10.1016/j.it.2016.07.006

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  24 in total

1.  Clonally expanded γδ T cells protect against Staphylococcus aureus skin reinfection.

Authors:  Carly A Dillen; Bret L Pinsker; Alina I Marusina; Alexander A Merleev; Orly N Farber; Haiyun Liu; Nathan K Archer; Da B Lee; Yu Wang; Roger V Ortines; Steven K Lee; Mark C Marchitto; Shuting S Cai; Alyssa G Ashbaugh; Larissa S May; Steven M Holland; Alexandra F Freeman; Loren G Miller; Michael R Yeaman; Scott I Simon; Joshua D Milner; Emanual Maverakis; Lloyd S Miller
Journal:  J Clin Invest       Date:  2018-02-05       Impact factor: 14.808

Review 2.  T cells and autoimmune kidney disease.

Authors:  Abel Suárez-Fueyo; Sean J Bradley; David Klatzmann; George C Tsokos
Journal:  Nat Rev Nephrol       Date:  2017-03-13       Impact factor: 28.314

3.  Cerebrospinal fluid γδ T cell frequency is age-related: a case-control study of 435 children with inflammatory and non-inflammatory neurological disorders.

Authors:  M R Pranzatelli; T J Allison; N R McGee; E D Tate
Journal:  Clin Exp Immunol       Date:  2018-03-24       Impact factor: 4.330

4.  Identification of a tumor-specific allo-HLA-restricted γδTCR.

Authors:  G J J Kierkels; W Scheper; A D Meringa; I Johanna; D X Beringer; A Janssen; M Schiffler; T Aarts-Riemens; L Kramer; T Straetemans; S Heijhuurs; J H W Leusen; E San José; K Fuchs; M Griffioen; J H Falkenburg; L Bongiovanni; A de Bruin; D Vargas-Diaz; M Altelaar; A J R Heck; L D Shultz; F Ishikawa; M I Nishimura; Z Sebestyén; J Kuball
Journal:  Blood Adv       Date:  2019-10-08

Review 5.  γδ T cells in rheumatic diseases: from fundamental mechanisms to autoimmunity.

Authors:  Cuong Thach Nguyen; Emanual Maverakis; Matthias Eberl; Iannis E Adamopoulos
Journal:  Semin Immunopathol       Date:  2019-09-10       Impact factor: 9.623

6.  Activation of Human Vδ2+ γδ T Cells by Staphylococcus aureus Promotes Enhanced Anti-Staphylococcal Adaptive Immunity.

Authors:  Andrew J R Cooper; Stephen J Lalor; Rachel M McLoughlin
Journal:  J Immunol       Date:  2020-07-10       Impact factor: 5.422

7.  Potent Bidirectional Cross-Talk Between Plasmacytoid Dendritic Cells and γδT Cells Through BTN3A, Type I/II IFNs and Immune Checkpoints.

Authors:  Pauline Girard; Benedicte Ponsard; Julie Charles; Laurence Chaperot; Caroline Aspord
Journal:  Front Immunol       Date:  2020-05-06       Impact factor: 7.561

Review 8.  γδ T Cells in Antimalarial Immunity: New Insights Into Their Diverse Functions in Protection and Tolerance.

Authors:  Kathleen W Dantzler; Prasanna Jagannathan
Journal:  Front Immunol       Date:  2018-10-23       Impact factor: 7.561

9.  NK Cells and γδT Cells for Relapse Protection After Allogeneic Hematopoietic Cell Transplantation (HCT).

Authors:  Moniek A de Witte; Jürgen Kuball; Jeffrey S Miller
Journal:  Curr Stem Cell Rep       Date:  2017-10-16

Review 10.  PPAR agonists as effective adjuvants for COVID-19 vaccines, by modifying immunogenetics: a review of literature.

Authors:  Antoine Fakhry AbdelMassih; Rahma Menshawey; Jumana H Ismail; Reem J Husseiny; Yousef M Husseiny; Shenoda Yacoub; Aya Kamel; Rafeef Hozaien; Elaria Yacoub; Esraa Menshawey; Abanoub Abdelmalek; Ahmed Abouelazaem; Ahmed Elhatw; Ahmed Aboelmaaty; Alaaelrahman Shahib; Amany Mansour; Aya Kamal; Basant Mohamed; Bemen Atif; Beshoy Ghabreal; Catherine Abdelmalak; David Ibrahim; Ebtesam Elsaify; Farah Magdy; Farid G Hanna; Hadeer Hafez; Hafsa Dahir; Kerlos Merhom; Maram Ahmed; Mariam Bishara; Mina Tawfik; Mina Youssef; Mohamed El Sharnouby; Mourad Hamouda; Musheera Ammar; Nada Ali; Nada Daniel; Nadine El-Husseiny; Noha Abdelraouf; Nuran K Abdelhameed; Radwa Ahmed; Radwa Othman; Rahma Mohamadein; Rana Allam; Rana Elgendy; Rana Shebl; Saged Elsherbiney; Sarah Fouad; Sara Emel; Sara Owais; Sarah Hetta; Samah El-Saman; Shaimaa Abdelalim; Sherin Galal; Yara Asar; Yara Osman; Yasmeen Khalaf; Youstina Aziz; Yousra Khafagy; Nervana Gamal; Biagio Castaldi
Journal:  J Genet Eng Biotechnol       Date:  2021-05-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.